BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27172897)

  • 1. LTR12 promoter activation in a broad range of human tumor cells by HDAC inhibition.
    Krönung SK; Beyer U; Chiaramonte ML; Dolfini D; Mantovani R; Dobbelstein M
    Oncotarget; 2016 Jun; 7(23):33484-97. PubMed ID: 27172897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death.
    Beyer U; Krönung SK; Leha A; Walter L; Dobbelstein M
    Cell Death Differ; 2016 Jan; 23(1):64-75. PubMed ID: 26024393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of next-generation RNA-sequencing in identifying chimeric transcription involving human endogenous retroviruses.
    Sokol M; Jessen KM; Pedersen FS
    APMIS; 2016; 124(1-2):127-39. PubMed ID: 26818267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment.
    White CH; Beliakova-Bethell N; Lada SM; Breen MS; Hurst TP; Spina CA; Richman DD; Frater J; Magiorkinis G; Woelk CH
    Front Immunol; 2018; 9():603. PubMed ID: 29706951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes.
    Beyer U; Moll-Rocek J; Moll UM; Dobbelstein M
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3624-9. PubMed ID: 21300884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats.
    Brocks D; Schmidt CR; Daskalakis M; Jang HS; Shah NM; Li D; Li J; Zhang B; Hou Y; Laudato S; Lipka DB; Schott J; Bierhoff H; Assenov Y; Helf M; Ressnerova A; Islam MS; Lindroth AM; Haas S; Essers M; Imbusch CD; Brors B; Oehme I; Witt O; Lübbert M; Mallm JP; Rippe K; Will R; Weichenhan D; Stoecklin G; Gerhäuser C; Oakes CC; Wang T; Plass C
    Nat Genet; 2017 Jul; 49(7):1052-1060. PubMed ID: 28604729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
    Kim SN; Kim NH; Lee W; Seo DW; Kim YK
    Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and regulation of human endogenous retrovirus W elements.
    Li F; Karlsson H
    APMIS; 2016; 124(1-2):52-66. PubMed ID: 26818262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB and IRF1 Induce Endogenous Retrovirus K Expression via Interferon-Stimulated Response Elements in Its 5' Long Terminal Repeat.
    Manghera M; Ferguson-Parry J; Lin R; Douville RN
    J Virol; 2016 Oct; 90(20):9338-49. PubMed ID: 27512062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPM2 mediates histone deacetylase inhibition-induced apoptosis in bladder cancer cells.
    Cao QF; Qian SB; Wang N; Zhang L; Wang WM; Shen HB
    Cancer Biother Radiopharm; 2015 Mar; 30(2):87-93. PubMed ID: 25760728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of human endogenous retroviral long terminal repeat sequences in human cancer (Review).
    Yu HL; Zhao ZK; Zhu F
    Int J Mol Med; 2013 Oct; 32(4):755-62. PubMed ID: 23900638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At least 50% of human-specific HERV-K (HML-2) long terminal repeats serve in vivo as active promoters for host nonrepetitive DNA transcription.
    Buzdin A; Kovalskaya-Alexandrova E; Gogvadze E; Sverdlov E
    J Virol; 2006 Nov; 80(21):10752-62. PubMed ID: 17041225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity.
    Kang KA; Piao MJ; Kim KC; Zheng J; Yao CW; Cha JW; Kim HS; Kim DH; Bae SC; Hyun JW
    Int J Oncol; 2013 Dec; 43(6):1907-14. PubMed ID: 24100442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes.
    Wang JH; Shih KS; Wu YW; Wang AW; Yang CR
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1987-96. PubMed ID: 24107356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.
    Nordström L; Andersson E; Kuci V; Gustavsson E; Holm K; Ringnér M; Guldberg P; Ek S
    BMC Cancer; 2015 Apr; 15():273. PubMed ID: 25880212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter.
    Garrison PM; Rogers JM; Brackney WR; Denison MS
    Arch Biochem Biophys; 2000 Feb; 374(2):161-71. PubMed ID: 10666294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endogenous retroviral long terminal repeat is the dominant promoter for human beta1,3-galactosyltransferase 5 in the colon.
    Dunn CA; Medstrand P; Mager DL
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12841-6. PubMed ID: 14534330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.